Actively Recruiting
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
Led by Yonsei University · Updated on 2025-03-04
2000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to develop and validate a model that predicts heart function, especially the left ventricular ejection fraction (LVEF), by combining echocardiography results with body composition data from the QCCUNIQ BC 720 device. The study focuses on adults with and without heart failure to better understand how body composition relates to heart health and to enhance early detection of cardiac dysfunction. Participants will undergo standard echocardiographic exams to measure heart function and body composition analysis using the QCCUNIQ BC 720 device within one week of their heart scan. The study includes 2,000 adults split evenly between those with normal heart function (LVEF 6550%) and those with heart failure (LVEF below 50%). Researchers will analyze these data using traditional and advanced machine learning methods to create a predictive model. Throughout the study, participants will have their heart function and body composition assessed, with data collected on parameters like fat mass, muscle mass, and total body water. The study will track outcomes such as LVEF within one week and evaluate the model's accuracy through statistical validation. The goal is to find a non-invasive method to identify individuals at risk for heart problems, potentially reducing reliance on complex diagnostics and improving personalized care.
CONDITIONS
Brief Title
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 20 years or older
- Undergoing a standard echocardiographic examination
- Willing to undergo body composition analysis
- Able and willing to provide informed consent to participate voluntarily
You will not qualify if you...
- Having a physical or mental condition preventing echocardiogram or body composition analysis
- Deemed unsuitable for participation by the researcher due to inability to cooperate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Within 1 week
Participants undergo standard echocardiographic examination and body composition analysis using the ACCUNIQ BC720 device to collect cardiac and body composition data.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Yongin Severance Hospital
Yongin, Gyeonggi-do, South Korea, 16995
Actively Recruiting
Research Team
S
SungA Bae, MD., PhD.
I
In Hyun Jung, MD., PhD.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here